Ultra-long-term subcutaneous home monitoring of epilepsy-490 days of EEG from nine patients.

ABSTRACT:

Objective

To explore the feasibility of home monitoring of epilepsy patients with a novel subcutaneous electroencephalography (EEG) device, including clinical implications, safety, and compliance via the first real-life test.

Methods

We implanted a beta-version of the 24/7 EEG SubQ (UNEEG Medical A/S, Denmark) subcutaneously in nine participants with temporal lobe epilepsy. Data on seizures, adverse events, compliance in using the device, and use of antiepileptic drugs (AEDs) were collected. EEG was recorded for up to 3 months, and all EEG data were reviewed visually to identify electrographic seizures. These were descriptively compared to seizure counts and AED changes reported in diaries from the same period.

Results

Four hundred ninety days of EEG and 338 electrogr

SUBMITTER: Weisdorf S 

PROVIDER: S-EPMC6899579 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature